Why the study?
Does the monocyte/lymphocyte ratio predict the presence and severity of coronary artery disease better than the neutrophil to lymphocyte ratio?
Does the monocyte/lymphocyte ratio predict the presence and severity of coronary artery disease better than the neutrophil to lymphocyte ratio?
The monocyte/lymphocyte ratio may serve as a useful biomarker for predicting the presence and angiographic severity of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
MLR may aid CAD risk stratification via routine labs; leaves open prospective validation versus NLR.
Ji et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: